Clinical Trials

• Clinical Trials at Swedish Medical Center
• AIDS Clinical Trials Unit (ACTU) Has a New Study!

Clinical Trials at Swedish Medical Center

Tipranavir Early Access Program

There are limited openings in this program. Please contact Heather Algren at (206) 386-2820.

Protease Inhibitor Study

You may be eligible to join a research study of a medication for HIV disease if you have taken HIV medications in the past that no longer work for you and you are currently taking a combination of HIV medications and your viral load is over 1,000 copies. Please contact Janice Price at (206) 386-2523.

AIDS Clinical Trials Unit (ACTU) Has a New Study!

Correlation Between Drug Levels in the Blood & Resistance Testing

The study will evaluate the correlation between drug blood levels and resistance testing with viral load suppression for each of the three Ritonavir-boosted protease inhibitors.

Eligibility:

• On stable HAART for 90 days, with exposure to NRTI, NNRTI, and PIs
• HIV RNA of 2,500 copies/mL or above and evidence of RESISTANCE
• 13 years of age or older
• Men and Women (Women must not be pregnant)

Treatment:

The study will provide the following PI drug combinations + optimized background regimen of ZDV, 3TC, or Abacavir are chosen as background drugs.

1. Lopinavir/ritonavir + Ritonavir
2. Fosamprenavir/ritonavir (The FDA has approved GW-433908, which is a form of Amprenavir that requires fewer pills. However, its use in this trial is investigational)
3. Indinavir/ritonavir
4. Tenofovir added at day 15

Study will run for 24 weeks.

Exams and testing provided at no cost. $20 per study visit and $150 for one all-day visit.

Contact Carol Glenn at Madison Clinic or call the ACTU (206)-731-3184 and ask for the screening nurse on call. Thank you.